ASTRO awards early-career research grants to physician-scientists
ARLINGTON, Va., Sept. 18, 2017 — The American Society for Radiation Oncology (ASTRO) is awarding $275,000 in research awards to four early-career scientists as part of the Society's efforts to retain and foster the intellectual research talent currently entering the field of radiation oncology. For 2017, the Research Grants committee selected one Junior Faculty Award and three Resident Seed Grant recipients. All winners will be recognized at ASTRO's 59th Annual Meeting, taking place September 24-27, at the San Diego Convention Center.
"ASTRO may not conduct its own scientific research–but we aim to create an environment where researchers are able to succeed. These grants recognize the innovative work being done by those in our field, and they also identify and encourage early-career researchers," said ASTRO Chair David C. Beyer, MD, FASTRO. "By supporting these researchers, our specialty will benefit from their discoveries, which, in turn, will eventually lead to better outcomes for our patients–the ultimate goal we physicians strive for, every day."
The ASTRO Junior Faculty Career Research Training Award (JFA) gives early career physicians and researchers the opportunity to develop careers and focus on research relevant to radiation oncology, biology or physics. Recipients must be board-eligible physicians, physicists in radiation oncology or radiobiologists within the first three years of their junior faculty appointment. One junior faculty member was selected for this award, which provides $100,000 annually for two years.
The 2017 JFA grant recipient is Erina Vlashi, PhD, from the University of California, Los Angeles. Dr. Vlashi is interested in how ionizing radiation induces the reprogramming of breast cancer cells into breast-cancer-initiating or stem cells that can lead to increased tumor growth and treatment resistance. Understanding the steps in how radiation alters the metabolic state of breast tumor cells can provide key insights into how these cells will respond to subsequent ionizing radiation (IR) exposure.
The ASTRO Resident/Fellows in Radiation Oncology Research Seed Award supports residents or fellows who are planning a career in basic science or clinical research in radiation oncology. Three researchers were selected for this award, which provides $25,000 per recipient for one year. The three 2017 Resident/Fellows in Radiation Oncology Research Seed Award recipients are:
- Devarati Mitra, MD, PhD, from the Dana-Farber Cancer Institute, Boston. Dr. Mitra will investigate how administration of hypofractionated radiation modulates the immune response in head and neck carcinoma. He will explore if such modulation can increase the efficacy of immune checkpoint inhibitors when combined with radiation.
- Shushan Rana, MD, from the Oregon Health & Science University, Portland, Oregon. Dr. Rana will investigate how microRNA, specifically miR-15a, affects endothelial radiosensitivity through regulation of acid sphingomyelinase ceramide-induced apoptosis, a pathway which is preferentially induced at higher doses of radiation. He hopes to ultimately prevent the development of immune cell anergy and/or exhaustion to improve tumor responses to anti-tumor treatment.
- Ye Yuan, MD, from the University of California, Los Angeles. Dr. Yuan's interest is in how tumors evade the immune system through upregulation of PD-L1 and PD-L2 expression. Mediators that inhibit gene expression including micro-RNA molecules can be activated by radiation treatment. How radiation activates miR-34 that subsequently binds to and downregulates PD-L1 and PD-L2 expression still remains unclear and may be an effective way to stimulate the immune response to kill tumor cells.
All awardees must submit a report to ASTRO at the midterm and the conclusion of their research, and they are strongly encouraged to submit their study as an abstract to a subsequent ASTRO Annual Meeting. The grant winners are selected by ASTRO's Research Grants Evaluation Committee within the Science Council and approved by the ASTRO Board of Directors.
For more information about ASTRO's grants and awards, visit https://www.astro.org/Funding-Opportunities.aspx.
For more information about ASTRO's 59th Annual Meeting, visit http://www.astro.org/AnnualMeeting. For press registration and media policies for ASTRO's 59th Annual Meeting, visit http://www.astro.org/AMPress.
ABOUT ASTRO'S ANNUAL MEETING
ASTRO's 59th Annual Meeting, the nation's premier scientific meeting in radiation oncology, will be held September 24-27, 2017, at the San Diego Convention Center. The 2017 Annual Meeting is expected to attract more than 11,000 attendees from across the globe, including oncologists from all disciplines and members of the entire radiation oncology team. More than 2,800 abstracts sharing results from clinical trials and other research studies will be presented in conjunction with educational sessions and keynote addresses that underscore the meeting's theme, "The Healing Art and Science of Radiation Oncology." Led by ASTRO President Brian Kavanagh, MD, MPH, FASTRO, the 2017 meeting will feature keynote addresses from Richard D. Zane, MD, FAAEM, Chief Innovation Officer for the University of Colorado Health System; Lucy Kalanithi, MD, FACP, widow of Paul Kalanithi, MD, the best-selling author of "When Breath Becomes Air," with Heather Wakelee, MD, her late husband's oncologist; and Vinay K. Prasad, MD, MPH, an assistant professor of medicine at the Oregon Health & Science University. During the four-day meeting, more than 200 exhibitors will demonstrate cutting-edge technology and medical device innovations for radiation oncology. Visit us online for more information about ASTRO's 59th Annual Meeting or press opportunities at the meeting.
ASTRO is the world's largest radiation oncology society, with members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes three medical journals, International Journal of Radiation Oncology * Biology * Physics , Practical Radiation Oncology and Advances in Radiation Oncology; developed and maintains an extensive patient website, RT Answers ; and created the Radiation Oncology Institute , a nonprofit foundation to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. To learn more about ASTRO, visit http://www.astro.org.